We determined that IL-37 expression was significantly associated with tumor size (P=0.046), tumor Barcelona Clinic Liver Cancer (BCLC) staging (P=0.030) and microvascular invasion (P=0.046) (Table 1). Here, IL37 is linked to liver cancer.